HelixNano Competitors and Similar CompaniesClear all

HelixNano's competitors and similar companies include Eutropics, ONK Therapeutics and Monte Rosa Therapeutics.
HelixNano
HelixNano
HelixNano (also known as Helix Nanotechnologies) is a biotechnology company that develops an mRNA platform.
Eutropics
Eutropics
Eutropics Pharmaceuticals is a company that develops predictive diagnostic tests for guiding patient cancer treatments.
ONK Therapeutics
ONK Therapeutics
ONK Therapeutics is a company that develops natural killer cell-based therapies intended to target blood cancer with unmet needs.
Monte Rosa Therapeutics
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways.
Founding Date
Founding Date
2013
Founding Date
2005
Founding Date
2015
Founding Date
2018
Type
Type
Private
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
Cambridge, US HQ
Locations
Barna, IE HQ
Locations
Boston, US HQ
Basel, CH
Basel, CH
Basel, CH
Boston, US
Cambridge, US
Employees
Employees
248% decrease
Employees
5
Employees
176% decrease
Employees
75

Funding

Latest funding round
Latest funding round
$ 50k (about 6 years ago)
Latest funding round
N/A
Latest funding round
$ 8m (over 5 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 6.4m
Total funding raised
N/A
Total funding raised
$ 14.6m
Total funding raised
$ 223.5m
For sources of this data, please see the company profile

View Company Profiles

Eutropics
HQ
Cambridge, US
Employees
5

Eutropics Pharmaceuticals is a company that develops predictive diagnostic tests for guiding patient cancer treatments.

View company
ONK Therapeutics
HQ
Barna, IE
Employees
17↓ 6% decrease

ONK Therapeutics is a company that develops natural killer cell-based therapies intended to target blood cancer with unmet needs.

View company
Monte Rosa Therapeutics
HQ
Boston, US
Employees
75

Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways.

View company